Wellgistics Health and Datavault AI to Form DelivMeds AI via PharmacyChain™ License Expansion and Acquisitions of QOLPOM Biometric Health Data and Drone Logistics IP and Majority of Tollo Health :: Datavault AI Inc. (DVLT)
Publish Date: 2026-05-20 09:14:00
Source Domain: ir.datavaultsite.com
-
Formation of DelivMeds AI, Inc.: Datavault AI and Wellgistics Health have formed DelivMeds AI, which has an expected combined asset value of approximately $4 billion. This formation is pending an independent fairness opinion.
-
Expansion of PharmacyChain™ License: Datavault AI has expanded its PharmacyChain™ license to encompass Healthcare-as-a-Service (HaaS) intellectual property. This expansion connects DelivMeds AI to Wellgistics’ 6,500+ pharmacies and 200+ manufacturers, integrating blockchain for healthcare data management.
-
QOLPOM Patent Portfolio Acquisition: DelivMeds AI has acquired QOLPOM patents that include technology for biometric verification for drug responses and drone-enabled medical delivery. This adds capabilities for remote biometric verification and patient-specific delivery.
-
Acquisition of Tollo Health: DelivMeds AI has acquired a controlling stake in Tollo Health, which focuses on muscle loss due to weight loss therapies, Long COVID, and acute/chronic viral infection management. This acquisition enhances DelivMeds AI’s medical food and dietary supplement offerings.
-
Health Lives Here Launch: A consumer health program named “Health Lives Here” is set to roll out nationally through the Wellgistics Pharmacy Network starting in July 2026. The program will launch officially in August 2026 as part of the Pro Football Hall of Fame Game.
-
Gerald Commissiong’s Role: Gerald Commissiong has been appointed as Interim Co-CEO of Wellgistics Health, supporting the initiatives and strategic goals of DelivMeds AI.
